Tag: treat

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

April 10, 2025 16:05 ET  | Source: Adaptive Biotechnologies SEATTLE, April 10,…

GlobeNews Wire GlobeNews Wire

AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal

OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM”…

GlobeNews Wire GlobeNews Wire

Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone”…

GlobeNews Wire GlobeNews Wire

ACTG Presents Data from Mpox Study STOMP at CROI

LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical…

GlobeNews Wire GlobeNews Wire

Hudson Therapeutics, the U.S. Subsidiary of Shaperon, Announces Initiation of Phase 2b Part 2 Clinical Trial for NuGel

Next-Generation Atopic Dermatitis Treatment Moves Forward with Global Development and Licensing Opportunities…

Business Wire Business Wire

Dupixent (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD

Five times more adults on Dupixent achieved sustained disease remission at 36…

GlobeNews Wire GlobeNews Wire

EMFACE Surpasses 1 Million Treatments, Becoming the Fastest-Growing Non-Invasive Facial Lifting Procedure

PRAGUE, March 5, 2025 /PRNewswire/ -- EMFACE, the revolutionary non-invasive facial treatment, has…

PRNW Agency PRNW Agency

BTL’s EMFACE Surpasses 1 Million Treatments, Becoming the Fastest-Growing Non-Invasive Facial Lifting Procedure

PRAGUE, March 5, 2025 /PRNewswire/ -- EMFACE, the revolutionary non-invasive facial treatment, has…

PRNW Agency PRNW Agency

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

February 28, 2025 17:00 ET  | Source: Keros Therapeutics, Inc. LEXINGTON, Mass.,…

GlobeNews Wire GlobeNews Wire

Sensorion Announces Its Participation in Several Investor Conferences to be Held in March

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology…

Business Wire Business Wire